AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,782.00p
   
  • Change Today:
      82.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.66m
  • Volume: 1,034,912
  • Market Cap: £167,192m
  • RiskGrade: 123

Latest Deals

Traded Action Notifier PriceAmountValue
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
21-May-25 Transfer From Pascal Soriot 0.000p 8,970 £0.00

Director Shareholdings

Notifier Holding Value*
Pascal Soriot 882,891 £95,193,308
Aradhana Sarin 118,367 £12,762,330
Marcus Wallenberg 60,028 £6,472,219
Michel Demare 10,000 £1,078,200
Philip A J Broadley 8,025 £865,256
Tony Mok 3,500 £377,370
Sheri McCoy 1,736 £187,176
Diana Layfield 1,400 £150,948
Karen Knudsen 1,400 £150,948
Euan Ashley 1,150 £123,993
Nazneen Rahman 1,017 £109,653
Anna Manz 487 £52,508

Major Shareholders

Notifier** Holding Value*
BlackRock, Inc 100,885,181 £10,877,440,215
Oddo Meriten Asset Management SA 100,885,181 £10,877,440,215
The Capital Group Companies, Inc. 77,540,115 £8,360,375,199
Wellington Management Company LLP 65,118,411 £7,021,067,074
Investor AB 51,587,810 £5,562,197,674

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,782.00p
Change Today 82.00p
% Change 0.77 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,034,912
Shares Issued 1,550.66m
Market Cap £167,192m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income
61.92% below the market average61.92% below the market average61.92% below the market average61.92% below the market average61.92% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.35% above the market average86.35% above the market average86.35% above the market average86.35% above the market average86.35% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 06-Jun-2025

Time Volume / Share Price
16:27 0 @ 10,764.00p
16:15 0 @ 10,764.00p
16:08 0 @ 10,756.00p
16:26 14 @ 10,766.00p
16:25 3 @ 10,768.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page